Presentation by CEO Martin Vidaeus of Redwood Pharma in Stockholm, Sep. 14, 2022
Redwood CEO Martin Vidaeus of Redwood Pharma presented at the BioStock Investor Meeting in Stockholm on Sep. 14, 2022. Martin provided a company update regarding the development of its RP501 and RP101 programs, as well as plans for the commercialization and launch of RP501. To see the presentation follow the link below.